Respiratory syncytial virus Clinical Trials in Chiang Mai
2 recruitingChiang Mai, Thailand
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
RSV InfectionRespiratory Syncytial Virus (RSV)RSV
Enanta Pharmaceuticals, Inc150 enrolled8 locationsNCT07482657
Recruiting
Phase 2
Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV
Respiratory Syncytial Virus (RSV)
PENTA Foundation120 enrolled8 locationsNCT06873633